Unlocking Comprehensive Epilepsy Care: The Dual Promise of Magnetoencephalography Authors: Dong Wook Kim Published: 2025 In patients with drug-resistant epilepsy, surgical intervention can be an important therapeutic option; however, its success depends critically on the precise localization of the epileptogenic zone.1,2 In this issue, an extensive qualitative systematic review, “Clinical Utility of Magnetoencephalography in Epilepsy Evaluation: A Qualitative Systematic Review”, sheds crucial light on the escalating importance of magnetoencephalography (MEG) in presurgical planning, particularly when it is integrated with other diagnostic modalities.3 This review, encompassing nine studies and 354 focal epilepsy patients, meticulously examined MEG’s performance of MEG, both as an isolated technique and in combination with other neuroimaging tools, such as high-density electroencephalogram (EEG), positron emission tomography, and magnetic resonance imaging (MRI). The review concluded that MEG can be useful in several ways. Although MEG alone demonstrated commendable localization accuracy of up to 77%, its power was amplified when combined with other diagnostic modalities. For instance, one study highlighted that combining MEG with high-density EEG achieved 91.3% diagnostic accuracy for surgical resection site prediction, a significant improvement from MEG alone (33.33%). Beyond localizing seizures, MEG excels at noninvasively mapping the eloquent cortex (areas critical for motor, sensory, and language functions), minimizing the risk of postoperative neurological deficits. This is particularly beneficial in children, where functional reorganization can make typical anatomical landmarks unreliable. The impact of MEG on surgical outcome outcomes was remarkable. While MEG alone yielded Engel class I seizure freedom rates ranging from 46.5% to 68.8%, its combined use with other techniques often resulted in seizure-free rates exceeding 90%. This finding underscores the synergistic effect of a multimodal approach. This review emphasized MEG’s effectiveness in pediatric patients and those with MRI-negative epilepsy, where it frequently achieved over 80% localization and seizure-free rates. This is important for children with focal cortical dysplasia and in cases where conventional MRI fails to identify a lesion, guiding critical surgical decision-making. Finally, MEG has merits in cost-effectiveness and reduced invasiveness. Canadian economic evaluations cited in the review suggest that despite higher initial costs, MEG is long-term cost-effective, improving quality-adjusted life years, and potentially reducing the need for more invasive procedures such as intracranial EEG. The utility of MEG in patients with epilepsy with non-surgical conditions is still limited. However, MEG may have potential roles in non-surgical cases because it is not merely an alternative diagnostic tool but a crucial complementary one, offering unique, high spatial resolution insights into neuronal activity that other techniques may not detect.4 In acute, life-threatening situations such as refractory status epilepticus, where invasive EEG may be poorly tolerated, MEG offers a noninvasive means to characterize the source of ongoing seizures. This diagnostic clarity can profoundly influence immediate medical management and guide critical treatment adjustments, even when surgery is not the primary intervention. For patients who are not surgical candidates or who choose not to undergo surgery, MEG’s precise localization of seizure onset can inform and optimize pharmacological strategies. A clearer understanding of the epileptogenic network allows clinicians to tailor antiepileptic medication regimens more effectively, potentially improving seizure control and reducing adverse effects. However, the review also highlights significant disparities in access and utilization, particularly in South Korea. Despite policy support for reimbursement, the nation currently operates only one MEG system, leading to limited accessibility and underutilization of the technology. With an estimated 2,500 patients annually requiring MEG, the current usage figures (approximately 150–160 cases per year) reveal a significant gap between clinical need and available resources. This geographical concentration of advanced technology further exacerbates regional health inequities.